Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -2.20 |
| peg ratio | 0.73 |
| price to book ratio | -5.43 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -3.74 |
| price fair value | -5.43 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -122.03% |
| return on equity | 4263.3% |
| return on capital employed | -139.27% |
liquidity ratio | |
|---|---|
| current ratio | 3.40 |
| quick ratio | 3.40 |
| cash ratio | 2.88 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 833.33 |
| cash conversion cycle | -833.33 |
| receivables turnover | 0.00 |
| payables turnover | 0.44 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.16 |
| debt equity ratio | -0.33 |
| long term debt to capitalization | -0.39 |
| total debt to capitalization | -0.49 |
| interest coverage | -182.59 |
| cash flow to debt ratio | -6.66 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.05 |
| cash per share | 1.92 |
| operating cash flow per share | -3.05 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -6.66 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -986.05 |
Frequently Asked Questions
When was the last time Elicio Therapeutics, Inc. (NASDAQ:ELTX) reported earnings?
Elicio Therapeutics, Inc. (ELTX) published its most recent earnings results on 13-11-2024.
What is Elicio Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Elicio Therapeutics, Inc. (NASDAQ:ELTX)'s trailing twelve months ROE is 4263.3%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Elicio Therapeutics, Inc. (ELTX) currently has a ROA of -122.03%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ELTX's net profit margin stand at?
ELTX reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ELTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.40 in the most recent quarter. The quick ratio stood at 3.40, with a Debt/Eq ratio of -0.33.